INVO Fertility, Inc. Interest Expense Nonoperating
INVO Fertility, Inc. (IVF) reported Interest Expense Nonoperating of $177.23 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- INVO Fertility, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $177.23K, a 59.78% decline year-over-year.
- INVO Fertility, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $180.32K, a 41.42% decline year-over-year.
- INVO Fertility, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $627.11K, a 197.76% increase year-over-year.
- INVO Fertility, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $145.80K, a 46.72% decline year-over-year.
- INVO Fertility, Inc. interest expense nonoperating for fiscal 2025 was $1.30M, a 25.79% increase from fiscal 2024.
- INVO Fertility, Inc. interest expense nonoperating for fiscal 2024 was $1.04M, a 11.80% increase from fiscal 2023.
- INVO Fertility, Inc. interest expense nonoperating for fiscal 2023 was $925.91K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $177.23K 10-Q · filed 2026-08-14 | $357.55K 10-Q · filed 2026-08-14 | $984.66K derived: sum of 3 quarters · filed 2026-08-14 | $1.13M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $180.32K 10-Q · filed 2026-06-22 | $807.43K derived: sum of 2 quarters · filed 2026-06-22 | $953.23K derived: sum of 3 quarters · filed 2026-06-22 | $1.39M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $627.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $772.91K derived: sum of 2 quarters · filed 2026-06-02 | $1.21M derived: sum of 3 quarters · filed 2026-08-14 | $1.30M 10-K · filed 2026-06-02 | |||
| 2025-09-30 | $145.80K 10-Q · filed 2025-11-17 | $586.40K derived: sum of 2 quarters · filed 2026-08-14 | $674.97K 10-Q · filed 2025-11-17 | $1.10M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $440.60K 10-Q · filed 2026-08-14 | $221.32K 10-Q · filed 2025-08-14 | $748.43K 10-Q · filed 2026-08-14 | $529.16K 10-Q · filed 2025-08-14 | $959.04K derived: sum of 3 quarters · filed 2026-08-14 | $1.23M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $307.84K 10-Q · filed 2026-06-22 | $311.27K 10-Q · filed 2025-05-20 | $518.45K derived: sum of 2 quarters · filed 2026-06-22 | $792.08K derived: sum of 3 quarters · filed 2026-06-22 | $1.16M derived: sum of 4 quarters · filed 2026-06-22 | ||
| 2024-12-31 | $210.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | $484.24K derived: sum of 2 quarters · filed 2026-06-02 | $853.85K derived: sum of 3 quarters · filed 2026-06-02 | $1.04M 10-K · filed 2026-06-02 | $1.06M 10-K · filed 2025-04-30 | ||
| 2024-09-30 | $273.63K 10-Q · filed 2025-11-17 | $643.24K derived: sum of 2 quarters · filed 2025-11-17 | $824.54K 10-Q · filed 2025-11-17 | $1.01M derived: sum of 4 quarters · filed 2025-11-17 | |||
| 2024-06-30 | $369.61K 10-Q · filed 2025-08-14 | $550.91K 10-Q · filed 2025-08-14 | $732.95K derived: sum of 3 quarters · filed 2025-08-14 | $1.09M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $181.29K 10-Q · filed 2025-05-20 | $363.34K derived: sum of 2 quarters · filed 2025-05-20 | $715.42K derived: sum of 3 quarters · filed 2025-05-20 | $890.62K derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | $182.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-30 | $534.13K derived: sum of 2 quarters · filed 2025-04-30 | $709.32K derived: sum of 3 quarters · filed 2025-04-30 | $925.91K 10-K · filed 2025-04-30 | |||
| 2023-09-30 | $352.08K 10-Q · filed 2024-11-19 | $527.28K derived: sum of 2 quarters · filed 2024-11-19 | $743.87K 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | $175.19K 10-Q/A · filed 2024-11-19 | $391.78K 10-Q/A · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |